Equities

Plant Health Care PLC

Plant Health Care PLC

Actions
  • Price (EUR)0.047
  • Today's Change0.016 / 51.61%
  • Shares traded0.00
  • 1 Year change-55.66%
  • Beta--
Data delayed at least 15 minutes, as of May 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Plant Health Care plc provides peptides for plant protection for global agricultural markets. The Company offers products to improve the health, vigor and yield of various field crops, such as corn, soybeans, potatoes and rice, as well as specialty crops, such as fruits and vegetables. It operates globally through subsidiaries, distributors and supply agreements with various industry partners. Its biological products help growers to protect their crops from stress and diseases, and to produce fruit and vegetables. Its segments include Americas, Mexico and Rest of World. The Americas segment includes activities in both North and South America. The Mexico segment includes sales of Harpinab and third-party products. Harpinab is sold as H2Copla into sugar cane in Brazil, through Coplacana, which is a distributor of inputs for this crop. The Rest of World segment includes operations of the United Kingdom and Spanish subsidiaries, which together operate across Europe and South Africa.

  • Revenue in GBP (TTM)9.44m
  • Net income in GBP-4.58m
  • Incorporated2004
  • Employees56.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.